| Authors: |
Sakatani T; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Tanaka S; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Murakami K; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Jinno C; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Aguilar F; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA., Bresee C; Biostatistics Shared Resources, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Chan OTM; Clinical and Translational Research Program, University of Hawaii Cancer Center, Honolulu, HI, USA., Luthringer DJ; Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Contreras-Sanz A; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Black P; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada., Rosser CJ; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Nonagen Therapeutics Corp, Los Angeles, CA 90010, USA., Furuya H; Samuel Oschin Comprehensive Cancer Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA; Department of Biomedical Science, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Electronic address: hideki.furuya@cshs.org. |
